Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 26 Pain, Postoperative 17 Neoplasms 13 Lung Neoplasms 12 Brain Neoplasms 12 Depression 7 Carcinoma, Hepatocellular 7 Pain 6 Colonic Neoplasms 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Prostatic Neoplasms 5 Leiomyoma 5 Head and Neck Neoplasms 5 Agnosia 5 Ovarian Neoplasms 4 Multiple Myeloma 4 Delirium 4 Colorectal Neoplasms 4 Anxiety Disorders 4 Supratentorial Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Myofibroma 3 Lymphoma 3 Hemorrhage 3 Fatigue 3 Emergence Delirium 3 Chronic Pain 3 Carcinoma, Non-Small-Cell Lung 3

Interventions

Ankle Brachial Index 2 Acetylcysteine 2 sodium thiosulfate 1 Tomography, X-Ray Computed 1 Saline Solution 1 Ringer's Lactate 1 Radiosurgery 1 Platinum 1 Ofloxacin 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Hearing Tests 1 Hearing 1 Genetic Association Studies 1 Ear Protective Devices 1 Cisplatin 1 Carboplatin 1 Audiometry, Pure-Tone 1 Acoustic Impedance Tests 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hearing Loss × Saline Solution × Clear all

NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

University of Oklahoma

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡